Insider Jamie Reynoso plans CLOV stock sale after prior 10b5-1 trades

Rhea-AI Filing Summary

Clover Health (CLOV) insider Jamie Reynoso has filed a notice to sell common stock under Rule 144. The notice covers 4,597 common shares to be sold through Morgan Stanley Smith Barney LLC on or around 01/20/2026 on the NASDAQ market, with an indicated aggregate market value of 11,676.38. These 4,597 shares were acquired as restricted stock units from the issuer on 01/15/2026.

The notice also lists prior sales of Clover Health common stock for the same account during the past three months, including 2,102 shares sold on 01/07/2026 for gross proceeds of 5,319.32, 4,913 shares sold on 12/18/2025 for 12,813.60, and 30,385 shares sold on 11/04/2025 for 108,854.26. The filing reports that 424,304,898 shares of the issuer’s common stock were outstanding at the time referenced in the notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4597	11676.38	424304898	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Restricted Stock Units	Issuer			4597	01/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	01/07/2026	2102	5319.32
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	12/18/2025	4913	12813.60
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	11/04/2025	30385	108854.26

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Clover Health (CLOV) shares are covered by Jamie Reynoso's new Rule 144 notice?

The notice covers 4,597 Clover Health common shares to be sold through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of 11,676.38.

When were the Clover Health (CLOV) shares in this Rule 144 notice acquired and how?

The 4,597 shares were acquired on 01/15/2026 as restricted stock units from the issuer, with the same date listed for payment and the nature of payment shown as N/A.

What recent Clover Health (CLOV) stock sales by Jamie Reynoso are disclosed in the past 3 months?

The notice lists three prior sales of Clover Health common stock for the same account: 2,102 shares sold on 01/07/2026 for 5,319.32, 4,913 shares sold on 12/18/2025 for 12,813.60, and 30,385 shares sold on 11/04/2025 for 108,854.26.

On which exchange and around what date are Jamie Reynoso's new Clover Health (CLOV) shares expected to be sold?

The 4,597 common shares covered by the notice are expected to be sold on the NASDAQ, with an approximate sale date of 01/20/2026.

How many Clover Health (CLOV) common shares are reported as outstanding in this notice?

The notice reports that 424,304,898 Clover Health common shares were outstanding at the time referenced, providing a baseline figure compared with the planned and recent insider sales.

Are Jamie Reynoso's recent Clover Health (CLOV) trades tied to a Rule 10b5-1 trading plan?

The section listing prior sales over the past three months describes them as "10b5-1 Sales for JAMIE REYNOSO", indicating those transactions were carried out under a Rule 10b5-1 trading arrangement.